DND Technologies, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNDT research report →
Companywww.dndtechnologies.com
DND Technologies, Inc. , a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis.
- CEO
- David Hong
- IPO
- 2013
- Employees
- 107
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $193.62K
- P/E
- -38.06
- P/S
- 0.00
- P/B
- -0.90
- EV/EBITDA
- -11.22
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 2.38%
- ROIC
- 2.86%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-49,500 · 2.89%
- EPS
- $-0.00 · 0.00%
- Op Income
- $-49,500
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.20
- 52W Low
- $0.04
- 50D MA
- $0.10
- 200D MA
- $0.08
- Beta
- -3.91
- Avg Volume
- 381
Get TickerSpark's AI analysis on DNDT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 11, 03 | GIFFHORN LOWELL | other | 150,000 |
Our DNDT Coverage
We haven't published any research on DNDT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DNDT Report →